These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7998235)

  • 1. Reversal of diabetes by intrapancreatic injection of aminoguanidine liposomes.
    Ricordi C; Behboo R; Klibanov A; Singal A; Huang L
    Transplant Proc; 1994 Dec; 26(6):3479. PubMed ID: 7998235
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro advanced glycation end product formation in rat tail tendon fibers: influence of aminoguanidine.
    Troncoso IA; Esteban MM; Ruiz MA; Flórez L; Barneo L
    Transplant Proc; 1995 Dec; 27(6):3345-6. PubMed ID: 8539985
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoguanidine, a potential drug for the treatment of diabetic complications.
    Wolffenbuttel BH; Huijberts MS
    Neth J Med; 1993 Jun; 42(5-6):205-8. PubMed ID: 8377878
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical aspects of therapy of diabetes mellitus with guanidine derivatives].
    Mohnike G
    Wien Z Inn Med; 1965 Jul; 46(7):257-65. PubMed ID: 5319733
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum.
    Shotton HR; Adams A; Lincoln J
    Auton Neurosci; 2007 Mar; 132(1-2):16-26. PubMed ID: 16987713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of lectin-modified insulin liposomes as carriers for oral administration.
    Zhang N; Ping QN; Huang GH; Xu WF
    Int J Pharm; 2005 Apr; 294(1-2):247-59. PubMed ID: 15814248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and expression of semicarbazide-sensitive benzylamine oxidase in a rodent model of diabetes: interactive effects with methylamine and alpha-aminoguanidine.
    Cioni L; De Siena G; Ghelardini C; Sernissi O; Alfarano C; Pirisino R; Raimondi L
    Eur J Pharmacol; 2006 Jan; 529(1-3):179-87. PubMed ID: 16325802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
    El Shazly AH; Mahmoud AM; Darwish NS
    Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testis glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase activities in aminoguanidine-treated diabetic rats.
    Unlüçerçi Y; Bekpinar S; Koçak H
    Arch Biochem Biophys; 2000 Jul; 379(2):217-20. PubMed ID: 10898937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of diabetes and aminoguanidine treatment on endothelial function in a primate model of type 1 diabetes.
    Brooks BA; Heffernan S; Thomson S; McLennan SV; Twigg SM; Yue DK
    Am J Primatol; 2008 Aug; 70(8):796-802. PubMed ID: 18481256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine prevented impairment of blood antioxidant system in insulin-dependent diabetic rats.
    Stoppa GR; Cesquini M; Roman EA; Ogo SH; Torsoni MA
    Life Sci; 2006 Feb; 78(12):1352-61. PubMed ID: 16229859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X; Diao Y; Zhang H; Huo X; Zhang Q
    Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats.
    Gül M; Emre S; Eşrefoğlu M; Vard N
    Cornea; 2008 Aug; 27(7):795-801. PubMed ID: 18650666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of chronic treatment with aminoguanidine on vascular properties in diabetic rat models].
    Levy BI; Struyker Boudier H; Wolfenbuttel B
    Therapie; 1997; 52(5):419-22. PubMed ID: 9501569
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats.
    Sugimoto K; Yagihashi S
    Microvasc Res; 1997 Mar; 53(2):105-12. PubMed ID: 9143541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats.
    Stadler K; Jenei V; Somogyi A; Jakus J
    Diabetes Metab Res Rev; 2005; 21(2):189-96. PubMed ID: 15386808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of aminoguanidine upon capillary and submesothelial anionic sites.
    Shostak A; Wajsbrot V; Gotloib L
    Microvasc Res; 2001 Mar; 61(2):166-78. PubMed ID: 11254396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
    Sannomiya P; Oliveira MA; Fortes ZB
    Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is there a role for pancreas transplantation in the treatment of type II diabetes mellitus? Experimental study].
    Elian N; Bensimon C; Chapa O; Bethoux JP; Cugnenc PH; Altman JJ
    Chirurgie; 1996; 121(2):144-50. PubMed ID: 8763121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.